Search for: "Janssen Research " Results 121 - 140 of 205
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Apr 2019, 7:45 am
In 1977 Edmund Kitch said that the grant of a patent could also have the purpose of encouraging further research on the patented subject matter, giving an analogy to a mining claim of staking out an area for further research. [read post]
3 Apr 2018, 5:00 am by Christina Spicer
” The plaintiff claims that Xarelto was inadequately researched and over-promoted, leading to his severe injuries. [read post]
9 Mar 2018, 5:00 am by Christina Spicer
One study, says the review, had to be discarded because of research flaws. [read post]
4 Mar 2008, 1:49 am
Janssen, discussing the new Federal Rules of Civil Procedure and their impact on litigators can be downloaded at [feeds.feedburner]. com/Westcast. [read post]
1 Aug 2008, 12:33 pm
§ 1407 and Transfers Actions to District of Minnesota Fifteen (15) individual and class action lawsuits were filed in seven (7) different federal district courts against Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc., and Johnson & Johnson Pharmaceutical Research & Development, among others, alleging “that the antibiotic Levaquin causes tendon rupture, and the warnings provided by defendants informing Levaquin users of… [read post]
16 Apr 2012, 8:26 pm
In fact, our attorneys brought a case against Orion Research Inc. and Baxter Health Care Corporation for a flawed test for the genetic disease cystic fibrosis. [read post]
10 Jun 2015, 11:51 am by Tom Lamb
  This news report from Medscape, "Four Diabetic Ketoacidosis Episodes Triple Risk of Early Death", provides a summary of and some contextual information about this important new medical study: In a cohort of adult patients with type 1 diabetes who were hospitalized with diabetic ketoacidosis (DKA) in Edinburgh, Scotland, almost all patients survived the hospitalization, but they had an increased risk of early death, new research shows. [read post]
10 Oct 2017, 5:00 am by melissalafreniere
According to the Xarelto gastrointestinal bleeding lawsuit, Janssen Research and Development, Johnson & Johnson, and Bayer negligently manufactured and marketed the drug. [read post]
7 Dec 2017, 5:00 am by melissalafreniere
Further, say researchers and physicians, Risperidone is not a “cure for autism. [read post]
11 Sep 2017, 5:00 am by melissalafreniere
The lawsuit goes on to allege that drug manufacturers Janssen Research and Development and Bayer Pharmaceuticals engaged in systemic discarding of medical records. [read post]
8 Aug 2017, 8:49 pm by Scott
Frank Smart, the chief of cardiology and a professor of medicine at Louisiana State University School of Medicine, told jurors that he came to his conclusion based on a combination of his own research, internal company emails from Xarelto blood thinner manufacturers Janssen Pharmaceuticals and Bayer, and transcripts of Food and Drug Administration (FDA) reviewers’ opinions, legal industry website MasssTortNexus.com reported. [read post]
29 Aug 2017, 5:00 am by melissalafreniere
Manufacturer Janssen Research & Development, an arm of Johnson & Johnson Pharmaceutical Research and Development LLC is named in the lawsuit for allegedly marketing a dangerous drug without giving patients or doctors appropriate information about the serious side effects, including life-threatening bleeding from Xarelto that could result. [read post]
29 Nov 2017, 10:41 am by Law Firm
Invokana is manufactured by Janssen Pharmaceuticals, a division of Johnson & Johnson. [read post]
29 May 2019, 6:57 am by Brian Lynch
Researchers combed through the FDA’s Adverse Event Reporting System and published case reports to compile their research. [read post]
2 Feb 2017, 7:42 am by Clay Hodges
Thousands of lawsuits have already been filed against Xarelto manufacturer Janssen Pharmaceuticals. [read post]
4 May 2017, 1:00 am by Jiao Yuxin
The clinical research of pharmaceutical polymorphs commenced in 1950s internationally though, it was until in mid-1990s did Chinese research institutions and pharmaceutical enterprises recognize the importance of pharmaceutical polymorphs after the first awareness of the significant efficacy difference between imported nimodipine and the homemade one. [read post]
28 Mar 2012, 2:59 am
FDA has a responsibility to protect the public's health and one step they must take to fulfill their mission is banning BPA as a food additive," said Sarah Janssen, an NRDC scientist. [read post]
24 Aug 2017, 5:00 am by melissalafreniere
The lawsuit argues that defendants Janssen Research and Development, an arm of Johnson & Johnson, should have been aware of the severe side effects that put patients at risk. [read post]
23 Jan 2018, 5:00 am by melissalafreniere
But, alleges the lawsuit, research shows that Xarelto is safer and more effective if taken twice a day and while patients are undergoing blood monitoring. [read post]